Rising serum CA-125 levels within the normal range is strongly associated recurrence risk and survival of ovarian cancer

Global surveillance of trends in cancer survival 2000–14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries

(2018) Claudia Allemani et al.   LANCET

The EUROCARE-5 study on cancer survival in Europe 1999–2007: Database, quality checks and statistical analysis methods

(2015) Silvia Rossi et al.   EUROPEAN JOURNAL OF CANCER

Does Aggressive Surgery Improve Outcomes? Interaction Between Preoperative Disease Burden and Complex Surgery in Patients With Advanced-Stage Ovarian Cancer: An Analysis of GOG 182

(2015) Neil S. Horowitz et al.   JOURNAL OF CLINICAL ONCOLOGY

CA-125–indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery

(2013) Fang Wang et al.   Journal of Ovarian Research

Prognostic Significance of Rising Serum CA-125 Levels Within the Normal Range in Patients With Epithelial Ovarian, Primary Peritoneal, and Tubal Cancers, Who, After Initial Treatment, Had a Complete Clinical Response

(2012) Tally Levy et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER

Lack of reliability of CA125 response criteria with anti-VEGF molecularly targeted therapy

(2008) Nilofer S. Azad et al.   CANCER

Serum CA-125 Level after 6 Cycles of Primary Adjuvant Chemotherapy Is a Useful Prognostic Factor for Complete Responders’ Survival in Patients with Advanced Epithelial Ovarian Cancer

(2008) Hee Seung Kim et al.   ONKOLOGIE